Latest biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Determinan las claves del éxito del trasplante de microbiota intestinal en personas con síndrome metabólico

by CSIC - Centro Superior de Investigaciones Científicas

2 years ago
trasplante de microbiota intestinal, MyNewGut

Un estudio coordinado por investigadores del Consejo Superior de Investigaciones Científicas (CSIC) ha evaluado el efecto del trasplante de microbiota intestinal en individuos con síndrome metabóli...

Disclosure of the mechanism that regulates the end of inflammation

by IRB Barcelona - Instituto de Investigación Biomédica

2 years ago
TTP protein, CPEB4 protein, RNA molecules

Scientists at IRB Barcelona led by ICREA researcher Dr. Raúl Méndez, head of the Translational Control of Cell Cycle and Differentiation lab, have described the cellular mechanism that coordinates t...

El proyecto 'Edad con Salud': una década de estudios sobre salud y bienestar en la población adulta española

by Cibersam- Centro de Investigación Biomédica en Red de Salud Mental

2 years ago
proyecto Edad con Salud

En un artículo publicado en The International Journal of Epidemiology, investigadores de la Universidad Autónoma de Madrid (UAM), el Parc Sanitari Sant Joan de Déu (Barcelona) y el CIBER de Salud M...

Identifican mutaciones en el gen ‘TECTA’ en la enfermedad de Meniere familiar

by CIBERER - Centro de Investigación Biomédica en Red de Enfermedades Raras

2 years ago
enfermedad de Meniere (EM) familiar, gen TECTA, ‘Otología y Otoneurología CTS495’

Investigadores del Grupo Clínico Vinculado al CIBERER liderado por José Antonio López-Escámez en la Universidad de Granada y el Instituto Biosanitario de Granada (ibs.GRANADA) han identificado un ...

On the ground at ASCO: two VHIO-led studies show the promise of immunotherapy for the treatment of advanced endometrial and cervical cancer

by VHIO

2 years ago
dostarlimab, endometrial cancer, GARNET study, bintrafusp alfa, cervical cancer, INTR@PID CERVICAL 046

Presented by Ana Oaknin, Principal Investigator of VHIO’s Gynecological Malignancies Group, during this week’s American Society of Clinical Oncology’s (ASCO) Annual Meeting, 03 – 07 June 2022,...

2022 ASCO Annual Meeting: the promise of novel antibody-drug conjugate sacituzumab govitecan and the policing of advanced/metastatic breast cancer by liquid biopsy

by VHIO

2 years ago
antibody-drug conjugate (ADC), sacituzumab govitecan, hormone receptor-positive/HER2-negative, TROPiCS-02, liquid biopsy

Co-authored by VHIO investigators, primary results from the multicenter TROPiCS-02 study of novel antibody-drug conjugate (ADC) sacituzumab govitecan in patients with hormone receptor-positive/HER2...

La UITM-CaixaResearch de VHIO presenta en ASCO avances en el desarrollo de nuevos fármacos

by VHIO

2 years ago
SOT101, AFM24, EGFR

La Unidad de Investigación de Terapia Molecular (UITM)-CaixaResearch tiene un papel destacado en el desarrollo de nuevos fármacos. Durante el Congreso Anual de la Sociedad Americana de Oncología Cl...

Liquid biopsy for predictive testing and prognosis in patients with advanced gastrointestinal stromal tumor (GIST)

by VHIO

2 years ago
Liquid biopsy, gastrointestinal stromal tumor (GIST), KIT mutation

Selected by the American Society of Clinical Oncology (ASCO) to first outing as an oral presentation*during its Annual Meeting, 03 – 07 June 2022, Chicago (IL, USA), results of a study led by César...

ASCO Annual Meeting 2022: VHIO-led studies report advances in the immune-based treatment of relapsed and metastatic lung cancer

by VHIO

2 years ago
lung cancer, ATLANTIS, lurbinectedin

Among VHIO-led research that was selected by the American Society of Clinical Oncology (ASCO) to first outing during its 2022 Annual Meeting, 03 – 07 June, Chicago (IL, USA), two studies have report...

VHIO at ASCO: VIGex predictive biomarker to immune checkpoint inhibitor pembrolizumab in patients with advanced disease

by VHIO

2 years ago
VIGex, liquid biopsy

The predictive power of VIGex in detecting those patients who are most likely to obtain clinical benefit from immunotherapy was initially validated in patients treated with ICIs in phase I immuno-onco...

Headlining at ASCO 2022: results of CheckMate 9ER exploratory analysis show depth of response to immune-based therapy associates with improved survival in patients with advanced renal cell carcinoma

by VHIO

2 years ago
CheckMate 9ER, sunitinib, CALYPSO, MET gene, papillary carcinoma, durvalumab and savolitinib

Kidney cancer (KC) ranks 14th in the most common cancers with 431,288 cases in 2020 and an estimated 179,368 deaths globally (1), with incidence on the rise. Clear cell renal cell carcinoma (ccRCC) is...

Los compuestos que dan color a la piel del tomate los protegen del calor y la radiación

by Fundación Andaluza para la Divulgación de la Innovación y el Conocimiento

2 years ago
flavona chalconaringenina, fenoles, cutícula de tomate

Un equipo de expertos del Instituto de Ciencias Materiales de Sevilla y el Instituto de Hortofruticultura Subtropical y Mediterránea ‘La Mayora’ ha demostrado que la acumulación en la epidermis ...